These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 12488382)
1. Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle. Azuma M; Yamane M; Tachibana K; Morimoto Y; Kemmotsu O Br J Anaesth; 2003 Jan; 90(1):66-71. PubMed ID: 12488382 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression. Hirabayashi Y; Igarashi T; Saitoh K; Fukuda H; Suzuki H; Shimizu R Acta Anaesthesiol Scand; 2000 Oct; 44(9):1128-33. PubMed ID: 11028735 [TBL] [Abstract][Full Text] [Related]
3. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS; Eardley D; Watkins R; Prioli N Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728 [TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor. Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731 [TBL] [Abstract][Full Text] [Related]
5. [Effects of olprynone hydrochloride and milrinone on the Ca(2+)-related functions of skinned skeletal muscle fibers from the guinea pigs]. Nakajima E Masui; 1999 Jul; 48(7):716-22. PubMed ID: 10434511 [TBL] [Abstract][Full Text] [Related]
6. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase. Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951 [TBL] [Abstract][Full Text] [Related]
7. Combined effects of volatile anesthetics and phosphodiesterase inhibitors on contractile performance in guinea pig hearts. Himmel HM; Schappert T; Ravens U Anesth Analg; 1991 Jul; 73(1):76-82. PubMed ID: 1713427 [TBL] [Abstract][Full Text] [Related]
8. The effect of phosphodiesterase III inhibitors on human neutrophil function. Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y Crit Care Med; 2000 Apr; 28(4):1001-5. PubMed ID: 10809273 [TBL] [Abstract][Full Text] [Related]
9. Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries. Onomoto M; Tsuneyoshi I; Yonetani A; Suehiro S; Matsumoto K; Sakata R; Kanmura Y Anesth Analg; 2005 Oct; 101(4):950-956. PubMed ID: 16192501 [TBL] [Abstract][Full Text] [Related]
10. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity. Heber D; Heers C; Ravens U Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts. Bethke T; Brunkhorst D; von der Leyen H; Meyer W; Nigbur R; Scholz H Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):576-82. PubMed ID: 2457816 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related]
13. Inotropic mechanisms of amrinone in papillary muscles from guinea-pig hearts. Mörner SE; Wohlfart B Acta Physiol Scand; 1990 Aug; 139(4):575-81. PubMed ID: 2248037 [TBL] [Abstract][Full Text] [Related]
14. Electropharmacological effects of UK-1745, a novel cardiotonic drug, in guinea-pig ventricular myocytes. Uemura H; Sakamoto N; Nakaya H Eur J Pharmacol; 1999 Nov; 383(3):361-71. PubMed ID: 10594330 [TBL] [Abstract][Full Text] [Related]
15. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: comparison of milrinone and amrinone. Hamada Y; Kawachi K; Yamamoto T; Nakata T; Kashu Y; Sato M; Watanabe Y Jpn Circ J; 1999 Aug; 63(8):605-9. PubMed ID: 10478810 [TBL] [Abstract][Full Text] [Related]
16. Effect of combining phosphodiesterase III inhibitors with St Thomas Hospital's solution used as transplantation preservative solution in isolated rat hearts. Besirli K; Burhani SM; Arslan C; Suzer O; Sayin AG Transplant Proc; 2006 Jun; 38(5):1253-8. PubMed ID: 16797275 [TBL] [Abstract][Full Text] [Related]
17. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone. Earl CQ; Linden J; Weglicki WB J Cardiovasc Pharmacol; 1986; 8(4):864-72. PubMed ID: 2427830 [TBL] [Abstract][Full Text] [Related]
18. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Sys SU; Goenen MJ; Chalant CH; Brutsaert DL Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662 [TBL] [Abstract][Full Text] [Related]
19. Low oxygen tension induces positive inotropy and decreases a(i)Na in isolated guinea-pig cardiac ventricular papillary muscles. Jao MJ; Yang JM Chin J Physiol; 1998 Jun; 41(2):101-6. PubMed ID: 9801840 [TBL] [Abstract][Full Text] [Related]
20. Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets. Malécot CO; Arlock P; Katzung BG J Pharmacol Exp Ther; 1985 Jan; 232(1):10-9. PubMed ID: 3965687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]